Necrotizing enterocolitis as an adverse effect of recombinant interleukin-2 and Ch14.18 in maintenance therapy for high-risk neuroblastoma

Journal of Pediatric Hematology/oncology
Gabriel LevyAnne-Sophie Defachelles

Abstract

Recombinant interleukin-2 is used with ch14.18/CHO to improve the cytotoxic activity of NK lymphocytes against neoplastic cells. The efficacy of this treatment is limited by its potential side effects. We report an unusual case of necrotizing enterocolitis associated with the administration of interleukin-2 and ch14.18/CHO in maintenance therapy for localized NMyc amplified neuroblastoma (NBL). This case highlights the potentially significant toxicity of this immunotherapy that is currently being tested in the high-risk NBL-1.5 protocol. Further, short-term, medium-term, and long-term follow-up in this patient population will be warranted to judge the potential benefit of this treatment versus the short-term, medium-term, and long-term side effects in a patient population with an outcome that is better than that of stage 4 NBL patients.

References

Aug 1, 1992·Journal of Immunotherapy·E WeidmannP S Mitrou
Jan 11, 1992·Cancer·D S WadeH O Douglass
Apr 13, 2004·Journal of Immunotherapy·David M Heimann, Douglas J Schwartzentruber
Jan 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katherine K MatthayJudith G Villablanca
Aug 25, 2009·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Tobias BöllingNormann Willich
Dec 25, 2009·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Agnieszka PrytułaKjell Tullus
Jun 23, 2010·Pediatrics·Daniela S ArdeleanSusanne M Benseler
Oct 1, 2010·The New England Journal of Medicine·Alice L YuUNKNOWN Children's Oncology Group

❮ Previous
Next ❯

Citations

Nov 16, 2018·Expert Opinion on Drug Safety·Katie L Greenwood, Jennifer H Foster
May 17, 2019·Immunotherapy·Parnian JabbariNima Rezaei
Jan 12, 2020·Pediatric Blood & Cancer·Katherine SpencerNavin Pinto

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

The New England Journal of Medicine
Clare M ReesAgostino Pierro
The New England Journal of Medicine
Phillip V Gordon
Radiologia diagnostica
E KolihováL Vondráková
Ryōikibetsu shōkōgun shirīzu
M Endo
© 2022 Meta ULC. All rights reserved